Christopher K. Cox - 20 Mar 2026 Form 4 Insider Report for Meta Platforms, Inc. (META)

Reporting relationship: Chief Product Officer
Issuer ticker: META
Reported as of: 20 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Mar 2026, 21:40:44 UTC
Prior SEC filing: 18 Feb 2026
Next SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Erin Guldiken, attorney-in-fact for Christopher K. Cox

Key filing fact

Christopher K. Cox filed Form 4 for Meta Platforms, Inc. (META) on 24 Mar 2026.

Key facts

This page summarizes Christopher K. Cox's Form 4 filing for Meta Platforms, Inc. (META).
8 reported transactions and 8 derivative rows are listed below.
Accepted by SEC: 24 Mar 2026, 21:40.

Change

Previous filing in this sequence was filed on 18 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001607459 Primary reporting owner

Cox Christopher K

Relationship: Chief Product Officer
Address: C/O META PLATFORMS, INC., 1 META WAY, MENLO PARK
Signature: /s/ Erin Guldiken, attorney-in-fact for Christopher K. Cox
Signature date: 24 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

META transaction Derivative

Restricted Stock Units (RSU) (Class A)

Award

Transaction value
Shares: +79,324
Change %
Price: $0.000000^*
Shares after: 79,324
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 79,324
Exercise price
Footnotes: F1, F2

META transaction Derivative

Stock Options (right to buy)

Award

Transaction value
Shares: +12,806
Change %
Price: $0.000000^*
Shares after: 12,806
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 12,806
Exercise price: $1116.08
Footnotes: F3, F4

META transaction Derivative

Stock Options (right to buy)

Award

Transaction value
Shares: +18,066
Change %
Price: $0.000000^*
Shares after: 18,066
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 18,066
Exercise price: $1393.87
Footnotes: F3, F4

META transaction Derivative

Stock Options (right to buy)

Award

Transaction value
Shares: +29,340
Change %
Price: $0.000000^*
Shares after: 29,340
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 29,340
Exercise price: $1724.41
Footnotes: F3, F4

META transaction Derivative

Stock Options (right to buy)

Award

Transaction value
Shares: +97,541
Change %
Price: $0.000000^*
Shares after: 97,541
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 97,541
Exercise price: $2114.87
Footnotes: F3, F4

META transaction Derivative

Stock Options (right to buy)

Award

Transaction value
Shares: +155,491
Change %
Price: $0.000000^*
Shares after: 155,491
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 155,491
Exercise price: $2573.06
Footnotes: F3, F4

META transaction Derivative

Stock Options (right to buy)

Award

Transaction value
Shares: +249,382
Change %
Price: $0.000000^*
Shares after: 249,382
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 249,382
Exercise price: $3107.44
Footnotes: F3, F4

META transaction Derivative

Stock Options (right to buy)

Award

Transaction value
Shares: +91,239
Change %
Price: $0.000000^*
Shares after: 91,239
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 91,239
Exercise price: $3727.12
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement.

Footnote F2

The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date.

Footnote F3

The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date.

Footnote F4

Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date.